New mutation linked to ovarian cancer can be passed down through dad

February 15, 2018, Public Library of Science
Fig 1. X-linked model. Schema for X-linked inheritance when cancer status is specific to women (all carrier men are effectively disease censored). Two family patterns with a pair of first-degree affected women are the maternal grandmother (MGM) family and the paternal grandmother (PGM) family. Stratton's paradox implies that PGM families are more likely under X-linkage because a father must pass the variant to all of his daughters. The rates are equal if the variant is autosomal. Credit: Kevin H. Eng and colleagues

A newly identified mutation, passed down through the X-chromosome, is linked to earlier onset of ovarian cancer in women and prostate cancer in father and sons. Kunle Odunsi, Kevin H. Eng and colleagues at Roswell Park Comprehensive Cancer Center in Buffalo, New York, report these findings February 15th, 2018, in PLOS Genetics.

In earlier studies, researchers noticed that when a woman develops ovarian , her sister faces a higher risk of also developing the disease than her mother, an observation they found difficult to explain. This observation led Eng and colleagues to investigate whether on the X-chromosome, potentially passed down through the father, may contribute to his daughters' risk of ovarian cancer.

Using the Familial Ovarian Cancer Registry, a donor-funded resource based at Roswell Park, the researchers collected information about pairs of granddaughters and grandmothers and sequenced portions of the X-chromosome from 186 women affected by the cancer. They found that cases of ovarian cancer linked to genes inherited from the paternal grandmother had an earlier age-of-onset than cases linked to , and were also associated with higher rates of in fathers and sons. Additional sequencing led the researchers to identify a previously unknown mutation on the X-chromosome that may be associated with cases of ovarian cancer that develop more than 6 years earlier that average.

The study proposes that a gene on the X-chromosome may contribute to a woman's risk of developing ovarian cancer, independently of other known , such as the BRCA genes. Future studies will be needed, however, to confirm the identity and function of this gene. This observation suggests that there may be many cases of seemingly sporadic ovarian cancer that are actually inherited, and may lead to improved cancer screening and better genetic risk assessment.

"Our study may explain why we find families with multiple affected daughters: because a dad's chromosomes determine the sex of his children, all of his daughters have to carry the same X-chromosome genes," says Eng, an assistant professor of oncology in Roswell Park's Department of Biostatistics and Bioinformatics. What we have to do next is make sure we have the right gene by sequencing more families. This finding has sparked a lot of discussion within our group about how to find these X-linked families. It's an all-or-none kind of pattern: A family with three daughters who all have is more likely to be driven by inherited X mutations than by BRCA mutations."

Explore further: USPSTF recommends against ovarian cancer screening

More information: Eng KH, Szender JB, Etter JL, Kaur J, Poblete S, Huang R-Y, et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14(2): e1007194.

Related Stories

USPSTF recommends against ovarian cancer screening

February 13, 2018
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends against screening for ovarian cancer in asymptomatic women. These findings form the basis of a final recommendation statement published in the Feb. ...

Research test identifies BRCA2 gene mutations that lead to breast, ovarian cancers

January 25, 2018
A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal ...

New ovarian cancer drug licensed for use

December 21, 2017
A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK.

Gene inheritance patterns influence age of diagnosis in BRCA families

December 12, 2011
Women who inherit the cancer genes BRCA1 or BRCA2 from their paternal lineage may get a diagnosis a decade earlier than those women who carry the cancer genes from their mother and her ancestors, according to a new study ...

Research uncovers more inherited genetic mutations linked to ovarian cancer

February 10, 2016
Previous research has established a link between genetic mutations in the BRCA1 and BRCA2 genes to an increased risk of developing ovarian, fallopian tube or peritoneal cancer in women. A recent publication documents the ...

Women's wellness: Early diagnosis for ovarian cancer

September 21, 2016
According to the Centers for Disease Control and Prevention, more than 20,000 women in the U.S. are diagnosed with ovarian cancer each year. September is Ovarian Cancer Awareness month and physicians want to raise awareness ...

Recommended for you

New methods find undiagnosed genetic diseases in electronic health records

March 15, 2018
Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases.

Hundreds of genes linked to intelligence in global study

March 14, 2018
More than 500 genes linked to intelligence have been identified in the largest study of its kind. Scientists compared variation in DNA in more than 240,000 people from around the world, to discover which genes are associated ...

Study finds that genes play a role in empathy

March 12, 2018
A new study published today suggests that how empathic we are is not just a result of our upbringing and experience but also partly a result of our genes.

Large-scale genetic study provides new insight into the causes of stroke

March 12, 2018
An international research consortium studying 520,000 individuals from around the world has identified 22 new genetic risk factors for stroke, thus tripling the number of gene regions known to affect stroke risk. The results ...

Study suggests some CpGs in the genome can be hemimethylated by design

March 9, 2018
A pair of researchers at Emory University has found that some CpGs in the genome can be hemimethylated by design, rather than by chance. In their paper published in the journal Science, Chenhuan Xu and Victor Corces describe ...

Intravenous arginine benefits children after acute metabolic strokes

March 9, 2018
Children with mitochondrial diseases who suffered acute metabolic strokes benefited from rapid intravenous treatment with the amino acid arginine, experiencing no side effects from the treatment. The diseases were caused ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.